US Integrates AI Agents into Medical Care Amid Safety and VC Influence Concerns

The Trump administration is rolling out federal projects that deploy AI agents for therapy and medication prescription, marking a significant policy shift toward AI integration in healthcare. Safety concerns and the role of venture capital investors in shaping these initiatives remain points of contention. This development signals a major change in US healthcare delivery and regulatory approach.